Daniel Faga Anaptysbio, Inc (ANAB) insider trading activity

Daniel Faga is President, CEO of ANAPTYSBIO, INC. Currently has a direct ownership of 479,344 shares of ANAB, which is worth approximately $16.2 Million. The most recent transaction as insider was on Jan 08, 2026, when has been sold 14,281 shares (Common Stock) at a price of $44.71 per share, resulting in proceeds of $638,503. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 479K

9.82% 3M change

9.82% 12M change

Total Value Held $16.2 Million

Daniel Faga Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2026	SELL Open market or private sale	$638,503 $44.71 p/Share	14,281 Reduced 2.89%	479,344 Common Stock
Jan 07 2026	SELL Open market or private sale	$415,102 $45.11 p/Share	9,202 Reduced 1.93%	466,787 Common Stock
Jan 07 2026	BUY Exercise of conversion of derivative security	-	26,838 Added 5.16%	493,625 Common Stock
Jan 06 2026	BUY Exercise of conversion of derivative security	-	17,850 Added 3.61%	475,989 Common Stock
Jan 05 2026	SELL Open market or private sale	$662,267 $43.26 p/Share	15,309 Reduced 3.23%	458,139 Common Stock
Jan 03 2026	BUY Exercise of conversion of derivative security	-	34,677 Added 6.82%	473,448 Common Stock
Jan 06 2025	SELL Payment of exercise price or tax liability	$97,721 $15.3 p/Share	6,387 Reduced 1.44%	436,466 Common Stock

Jan 06 2025	BUY Exercise of conversion of derivative security	-	17,850 Added 3.87%	442,853 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$190,281 $14.6 p/Share	13,033 Reduced 2.98%	425,003 Common Stock
Jan 03 2025	BUY Exercise of conversion of derivative security	-	34,678 Added 7.34%	438,036 Common Stock
Mar 26 2024	SELL Payment of exercise price or tax liability	$7,504,725 $21.6 p/Share	347,441 Reduced 46.38%	401,646 Common Stock
Mar 25 2024	SELL Open market or private sale	$64,260 $21.42 p/Share	3,000 Reduced 0.4%	749,087 Common Stock
Mar 22 2024	SELL Open market or private sale	$3,324,513 $22.78 p/Share	145,940 Reduced 16.25%	752,087 Common Stock
Jan 08 2024	SELL Open market or private sale	$149,747 $21.81 p/Share	6,866 Reduced 0.76%	898,027 Common Stock
Jan 06 2024	BUY Exercise of conversion of derivative security	-	17,850 Added 1.93%	904,893 Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	-	887,043 Added 50.0%	887,043 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

EVP, Chief Operating Officer

Daniel Faga

President, CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Value

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANAPTYSBIO, INC

Track Activities on ANAB

Account